{"id":16340,"date":"2026-03-13T11:51:15","date_gmt":"2026-03-13T10:51:15","guid":{"rendered":"https:\/\/blogdelarechercheclinique.com\/?p=16340"},"modified":"2026-03-16T10:01:03","modified_gmt":"2026-03-16T09:01:03","slug":"frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making","status":"publish","type":"post","link":"https:\/\/blogdelarechercheclinique.com\/en\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/","title":{"rendered":"How RWD and RWE Are Reshaping Regulatory Decision-Making"},"content":{"rendered":"<p><strong>In recent years, Real-World Data (RWD) and Real-World Evidence (RWE) have taken on a strategic role in regulatory decision-making.<\/strong> If you work in clinical research or regulatory affairs, you are probably already seeing it: agencies are no longer relying solely on randomized trials to evaluate treatments.<\/p>\n\n\n\n<p>Institutions such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Haute Autorit\u00e9 de Sant\u00e9 (HAS) have published several methodological frameworks to guide the use of real-world data.<\/p>\n\n\n\n<p>But in practice, how far can these data go? Under what conditions are they truly accepted by regulatory authorities?<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">RWD and RWE: two concepts that must be clearly distinguished<\/h2>\n\n\n\n<p>According to the U.S. Food and Drug Administration, <strong>Real-World Data (RWD)<\/strong> refers to data relating to patient health status and\/or the delivery of healthcare that are routinely collected from a variety of sources (electronic health records, patient registries, reimbursement claims, as well as health apps and connected devices). In short, anything that reflects patients\u2019 real-life experiences.<\/p>\n\n\n\n<p><strong>Real-World Evidence (RWE)<\/strong> refers to the clinical evidence regarding the usage, effectiveness, or safety of a medical product derived from the analysis of these data.<\/p>\n\n\n\n<p>In other words, <strong>RWD are the raw material<\/strong>, and <strong>RWE are the conclusions drawn from them to inform decision-making.<\/strong><\/p>\n\n\n\n<p>What makes these data particularly valuable is that they allow treatments to be observed in <strong>much broader and more diverse populations<\/strong> than those typically included in traditional clinical trials.<\/p>\n\n\n\n<p>If you would like to learn more about this topic, click here.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Why are authorities really interested in RWE?<\/h2>\n\n\n\n<p>Randomized clinical trials remain the gold standard. However, they are conducted in highly controlled environments. In real clinical practice, patients have comorbidities, receive multiple treatments, and adherence may vary depending on healthcare contexts.<\/p>\n\n\n\n<p>RWE therefore helps answer questions that clinical trials do not always address.<\/p>\n\n\n\n<p>In this context, the U.S. Food and Drug Administration developed its <strong>RWE Program<\/strong> to explore how Real-World Evidence can support label expansions for already approved drugs, fulfill post-authorization study requirements, and strengthen safety evaluations.<\/p>\n\n\n\n<p>Similarly, the European Medicines Agency launched the <strong>DARWIN EU\u00ae network (Data Analysis and Real-World Interrogation Network)<\/strong>, an initiative dedicated to analyzing real-world healthcare data from multiple European databases. Its objective is to rapidly generate analyses that support drug evaluation, pharmacovigilance activities, and broader regulatory decision-making across Europe.<\/p>\n\n\n\n<p>At the national level, several initiatives also structure access to health data. In France, the Health Data Hub facilitates access to and analysis of large health datasets, particularly those from the Syst\u00e8me National des Donn\u00e9es de Sant\u00e9 (SNDS), one of the largest medico-administrative databases in the world.<\/p>\n\n\n\n<p>These infrastructures enable large-scale real-world studies and help strengthen the generation of Real-World Evidence useful for research and health policy evaluation.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">How RWE are already influencing regulatory decisions<\/h2>\n\n\n\n<p>Today, RWE are used to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>confirm effectiveness or safety after <strong>Marketing Authorization (MA)<\/strong><\/li>\n\n\n\n<li>support <strong>label extensions<\/strong><\/li>\n\n\n\n<li>document populations poorly represented in clinical trials<\/li>\n\n\n\n<li>contribute to <strong>benefit\u2013risk reassessments<\/strong><\/li>\n\n\n\n<li>support certain <strong>reimbursement decisions<\/strong><\/li>\n<\/ul>\n\n\n\n<p>A frequently cited example concerns <strong>HR+\/HER2- advanced breast cancer<\/strong>. In this context, real-world data have been used to document the use of <strong>CDK4\/6 inhibitors<\/strong> in routine clinical practice and to complement the results of randomized clinical trials.<\/p>\n\n\n\n<p>After the initial approval of these treatments based on phase III trials, real-world analyses made it possible to evaluate their use in routine care, particularly among <strong>older patients or those receiving multiple medications<\/strong>, and to better characterize their safety profile in populations often under-represented in clinical trials.<\/p>\n\n\n\n<p>Interested in this topic? Click here to learn more.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">A warning: this is not \u201ceasy data\u201d<\/h2>\n\n\n\n<p>Real-World Evidence <strong>does not replace randomized clinical trials; it complements them.<\/strong><\/p>\n\n\n\n<p>Randomized trials remain the reference for establishing strong causal relationships thanks to randomization and bias control.<\/p>\n\n\n\n<p>RWE instead provides a broader and more realistic view of clinical practice, including more heterogeneous populations and diverse healthcare contexts.<\/p>\n\n\n\n<p>However, this richness comes with methodological challenges. Real-world data are often:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>heterogeneous across countries and healthcare systems<\/li>\n\n\n\n<li>incomplete or imperfectly coded<\/li>\n\n\n\n<li>exposed to biases that are more difficult to control<\/li>\n\n\n\n<li>less suitable for establishing direct causality<\/li>\n<\/ul>\n\n\n\n<p>For this reason, an RWE-based study can only be considered robust if its <strong>methodology is rigorous<\/strong>.<\/p>\n\n\n\n<p>Regulatory authorities closely examine:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>data quality and traceability<\/li>\n\n\n\n<li>bias management (selection bias, confounding bias, immortal time bias, etc.)<\/li>\n\n\n\n<li>statistical methods used (propensity scores, sensitivity analyses, adjusted models)<\/li>\n\n\n\n<li>pre-specification of analytical protocols<\/li>\n<\/ul>\n\n\n\n<p>Recommendations from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), as well as EMA and FDA guidelines, frame these methodological requirements.<\/p>\n\n\n\n<p>In other words, <strong>real-world research does not eliminate the need for scientific rigor.<\/strong><\/p>\n\n\n\n<p>This evolution is also reflected in the recent work of International Council for Harmonisation (ICH) within <strong>ICH E6(R3)<\/strong>. Its Annex 2, currently being finalized, addresses the integration of new data sources and more pragmatic study designs, including decentralized trials and other innovative approaches to data collection.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">A future where RWE become unavoidable<\/h2>\n\n\n\n<p>With the rise of digitalization, richer databases, and artificial intelligence, <strong>RWE are gaining importance.<\/strong><\/p>\n\n\n\n<p>Regulatory authorities are developing new guidelines, and pharmaceutical companies are investing in well-structured registries.<\/p>\n\n\n\n<p>All signs indicate that RWE will soon become a <strong>central pillar of the regulatory process<\/strong>.<\/p>\n\n\n\n<p>And for professionals working in clinical research or regulatory affairs, this means preparing for a future where these data will increasingly play a role in projects.<\/p>\n\n\n\n<p>At the European level, this transformation is also linked to the development of the European Health Data Space (EHDS), the future European health data space.<\/p>\n\n\n\n<p>This regulation aims to facilitate the <strong>secondary use of health data for research, innovation, and public policy evaluation<\/strong>. Its progressive implementation should eventually enable more harmonized use of health data across Europe.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p>Real-World Data and Real-World Evidence are gradually transforming how regulatory decisions are made.<\/p>\n\n\n\n<p>They provide a <strong>more realistic, comprehensive, and sometimes faster view<\/strong> of the impact of treatments in real-life conditions.<\/p>\n\n\n\n<p>Challenges remain significant, but the trend is clear: these data are becoming a lasting part of the regulatory landscape.<\/p>\n\n\n\n<p>In this context, new questions arise:<br>Could some regulatory decisions one day rely primarily \u2014 or even entirely \u2014 on Real-World Evidence?<br>And could these data eventually replace certain traditional clinical trials?<\/p>\n\n\n\n<p>The coming years may provide the answer.<\/p>\n\n\n\n<p><strong>Do you need support for a clinical research project?<\/strong><br>Contact <strong>Pharmaspecific<\/strong> by visiting our website and requesting a quote here:<br><a href=\"https:\/\/pharmaspecific.com\/devis\/\">https:\/\/pharmaspecific.com\/devis\/<\/a><\/p>\n\n\n\n<p>If you have questions about the <strong>Clinical Research Associate (CRA) profession<\/strong> or about building a career in clinical research, feel free to ask them in the comments below. We will respond as quickly as possible.<\/p>\n\n\n\n<p>If you are looking for <strong>training in clinical research<\/strong>, visit:<br><a href=\"https:\/\/pharmaspecific-training.com\/\">https:\/\/pharmaspecific-training.com\/<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>In recent years, Real-World Data (RWD) and Real-World Evidence (RWE) have taken on a strategic role in regulatory&#8230;<\/p>","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"facebook_122143508198123560_331463380343150":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[450,1],"tags":[66,41,92,8,888,889],"class_list":{"0":"post-16340","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-actualites-de-la-recherche-clinique","7":"category-non-classe","8":"tag-attache-de-recherche-clinique","9":"tag-cro","10":"tag-essai-clinique","11":"tag-recherche-clinique","12":"tag-rwd","13":"tag-rwe"},"translation":{"provider":"WPGlobus","version":"3.0.2","language":"en","enabled_languages":["fr","en"],"languages":{"fr":{"title":true,"content":true,"excerpt":false},"en":{"title":true,"content":true,"excerpt":false}}},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>How RWD and RWE Are Reshaping Regulatory Decision-Making  -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogdelarechercheclinique.com\/en\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How RWD and RWE Are Reshaping Regulatory Decision-Making  -\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogdelarechercheclinique.com\/en\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/blogdelarechercheclinique\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-13T10:51:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-16T09:01:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg\" \/>\n<meta name=\"author\" content=\"Virginie Smartelia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Virginie Smartelia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/\"},\"author\":{\"name\":\"Virginie Smartelia\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/ba5cec4b8139ceb5675ae6b489aee96a\"},\"headline\":\"How RWD and RWE Are Reshaping Regulatory Decision-Making\",\"datePublished\":\"2026-03-13T10:51:15+00:00\",\"dateModified\":\"2026-03-16T09:01:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/\"},\"wordCount\":2520,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg\",\"keywords\":[\"Attach\u00e9 de recherche clinique\",\"CRO\",\"essai clinique\",\"recherche clinique\",\"RWD\",\"RWE\"],\"articleSection\":[\"Actualit\u00e9s de la recherche clinique\",\"Non class\u00e9\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/\",\"url\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/\",\"name\":\"How RWD and RWE Are Reshaping Regulatory Decision-Making -\",\"isPartOf\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg\",\"datePublished\":\"2026-03-13T10:51:15+00:00\",\"dateModified\":\"2026-03-16T09:01:03+00:00\",\"description\":\"D\u00e9couvrez comment les Real-World Data (RWD) et Real-World Evidence (RWE) transforment les d\u00e9cisions r\u00e9glementaires et l\u2019\u00e9valuation des traitements.\",\"breadcrumb\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#primaryimage\",\"url\":\"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg\",\"contentUrl\":\"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/blogdelarechercheclinique.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comment les RWD et RWE r\u00e9volutionnent la prise de d\u00e9cision r\u00e9glementaire?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#website\",\"url\":\"https:\/\/blogdelarechercheclinique.com\/\",\"name\":\"Blog de la recherche clinique\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blogdelarechercheclinique.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#organization\",\"name\":\"Blog de la recherche clinique\",\"url\":\"https:\/\/blogdelarechercheclinique.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/04\/cropped-BLOG-logo.png?fit=512%2C512&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/04\/cropped-BLOG-logo.png?fit=512%2C512&ssl=1\",\"width\":512,\"height\":512,\"caption\":\"Blog de la recherche clinique\"},\"image\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/blogdelarechercheclinique\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/ba5cec4b8139ceb5675ae6b489aee96a\",\"name\":\"Virginie Smartelia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/40eb1ca17fda7289b368a199396a0fbcc0f3fedada553d4413d7cfe782e48413?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/40eb1ca17fda7289b368a199396a0fbcc0f3fedada553d4413d7cfe782e48413?s=96&d=mm&r=g\",\"caption\":\"Virginie Smartelia\"},\"url\":\"https:\/\/blogdelarechercheclinique.com\/en\/author\/virginie\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How RWD and RWE Are Reshaping Regulatory Decision-Making  -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogdelarechercheclinique.com\/en\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/","og_locale":"en_US","og_type":"article","og_title":"How RWD and RWE Are Reshaping Regulatory Decision-Making  -","og_url":"https:\/\/blogdelarechercheclinique.com\/en\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/","article_publisher":"https:\/\/www.facebook.com\/blogdelarechercheclinique","article_published_time":"2026-03-13T10:51:15+00:00","article_modified_time":"2026-03-16T09:01:03+00:00","og_image":[{"url":"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg","type":"","width":"","height":""}],"author":"Virginie Smartelia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Virginie Smartelia","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#article","isPartOf":{"@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/"},"author":{"name":"Virginie Smartelia","@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/ba5cec4b8139ceb5675ae6b489aee96a"},"headline":"How RWD and RWE Are Reshaping Regulatory Decision-Making","datePublished":"2026-03-13T10:51:15+00:00","dateModified":"2026-03-16T09:01:03+00:00","mainEntityOfPage":{"@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/"},"wordCount":2520,"commentCount":0,"publisher":{"@id":"https:\/\/blogdelarechercheclinique.com\/#organization"},"image":{"@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#primaryimage"},"thumbnailUrl":"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg","keywords":["Attach\u00e9 de recherche clinique","CRO","essai clinique","recherche clinique","RWD","RWE"],"articleSection":["Actualit\u00e9s de la recherche clinique","Non class\u00e9"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/","url":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/","name":"How RWD and RWE Are Reshaping Regulatory Decision-Making -","isPartOf":{"@id":"https:\/\/blogdelarechercheclinique.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#primaryimage"},"image":{"@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#primaryimage"},"thumbnailUrl":"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg","datePublished":"2026-03-13T10:51:15+00:00","dateModified":"2026-03-16T09:01:03+00:00","description":"D\u00e9couvrez comment les Real-World Data (RWD) et Real-World Evidence (RWE) transforment les d\u00e9cisions r\u00e9glementaires et l\u2019\u00e9valuation des traitements.","breadcrumb":{"@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#primaryimage","url":"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg","contentUrl":"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Sans-titre-2-1024x740.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/blogdelarechercheclinique.com\/frcomment-les-rwd-et-rwe-revolutionnent-la-prise-de-decision-reglementaireenhow-rwd-and-rwe-are-reshaping-regulatory-decision-making\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/blogdelarechercheclinique.com\/"},{"@type":"ListItem","position":2,"name":"Comment les RWD et RWE r\u00e9volutionnent la prise de d\u00e9cision r\u00e9glementaire?"}]},{"@type":"WebSite","@id":"https:\/\/blogdelarechercheclinique.com\/#website","url":"https:\/\/blogdelarechercheclinique.com\/","name":"Blog de la recherche clinique","description":"","publisher":{"@id":"https:\/\/blogdelarechercheclinique.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogdelarechercheclinique.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogdelarechercheclinique.com\/#organization","name":"Blog de la recherche clinique","url":"https:\/\/blogdelarechercheclinique.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/04\/cropped-BLOG-logo.png?fit=512%2C512&ssl=1","contentUrl":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/04\/cropped-BLOG-logo.png?fit=512%2C512&ssl=1","width":512,"height":512,"caption":"Blog de la recherche clinique"},"image":{"@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/blogdelarechercheclinique"]},{"@type":"Person","@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/ba5cec4b8139ceb5675ae6b489aee96a","name":"Virginie Smartelia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/40eb1ca17fda7289b368a199396a0fbcc0f3fedada553d4413d7cfe782e48413?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/40eb1ca17fda7289b368a199396a0fbcc0f3fedada553d4413d7cfe782e48413?s=96&d=mm&r=g","caption":"Virginie Smartelia"},"url":"https:\/\/blogdelarechercheclinique.com\/en\/author\/virginie\/"}]}},"jetpack_featured_media_url":"","jetpack-related-posts":[{"id":14895,"url":"https:\/\/blogdelarechercheclinique.com\/en\/quelle-destinee-pour-la-recherche-clinique-2-0\/","url_meta":{"origin":16340,"position":0},"title":"Quelle destin\u00e9e pour la recherche clinique 2.0 ?","author":"Vanessa Montanari","date":"21 September 2024","format":false,"excerpt":"R\u00e9dig\u00e9 par l'\u00e9quipe de Pharmaspecific. Introduction Ces derni\u00e8res ann\u00e9es, la technologie a r\u00e9volutionn\u00e9 presque tous les aspects de notre vie et la recherche clinique ne fait pas exception. Avec l\u2019av\u00e8nement de nouvelles technologies et l\u2019\u00e9volution constante des r\u00e9glementations, le r\u00f4le des Attach\u00e9s de Recherche Clinique (ARC)\u00a0 et Techniciens d\u2019\u00e9tude clinique\u2026","rel":"","context":"In &quot;Actualit\u00e9s de la recherche clinique&quot;","block_context":{"text":"Actualit\u00e9s de la recherche clinique","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/actualites-de-la-recherche-clinique\/"},"img":{"alt_text":"R\u00e9ussir un entretien t\u00e9l\u00e9phonique est donc la premi\u00e8re \u00e9tape vers le succ\u00e8s.","src":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/08\/entretien-telephonique.png?fit=986%2C657&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/08\/entretien-telephonique.png?fit=986%2C657&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/08\/entretien-telephonique.png?fit=986%2C657&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/08\/entretien-telephonique.png?fit=986%2C657&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":11620,"url":"https:\/\/blogdelarechercheclinique.com\/en\/textes-legislatifs-reglementaires-recherche-clinique\/","url_meta":{"origin":16340,"position":1},"title":"Comprendre les textes l\u00e9gislatifs ou r\u00e8glementaires en recherche clinique","author":"Vanessa Montanari","date":"26 January 2021","format":false,"excerpt":"il faut savoir que les textes juridiques sont hi\u00e9rarchis\u00e9s. En d\u2019autres termes, tous n\u2019ont pas la m\u00eame valeur juridique, la m\u00eame force.","rel":"","context":"In &quot;Les r\u00e8glementaires&quot;","block_context":{"text":"Les r\u00e8glementaires","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/reglementaires\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2021\/01\/textes-reglementaires.png?fit=460%2C295&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":16001,"url":"https:\/\/blogdelarechercheclinique.com\/en\/gel-de-base-comment-cela-impacte-votre-recherche-clinique\/","url_meta":{"origin":16340,"position":2},"title":"Achieving a Flawless Database Lock in Clinical Trials","author":"Virginie Smartelia","date":"20 March 2026","format":false,"excerpt":"Vous avez un gel de base ? Comprenez enfin son r\u00f4le, ses enjeux et ses implications dans la recherche clinique moderne.","rel":"","context":"In &quot;Non class\u00e9&quot;","block_context":{"text":"Non class\u00e9","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/non-classe\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":15858,"url":"https:\/\/blogdelarechercheclinique.com\/en\/lia-en-recherche-clinique-le-guide-simple-pour-les-petites-structures\/","url_meta":{"origin":16340,"position":3},"title":"AI in Clinical Research: The Simple Guide for Small Organizations.","author":"Virginie Smartelia","date":"7 October 2025","format":false,"excerpt":"{:fr} Solutions IA pour petites CRO et structures cliniques L'Intelligence Artificielle (IA) est l\u00e0, et elle bouscule tout, m\u00eame dans notre monde ultra-r\u00e9glement\u00e9. Que vous soyez dans une petite CRO, une PME Biotech, ou une \u00e9quipe op\u00e9rationnelle (ARC, TEC, Contract Specialist), l'IA est une chance folle de gagner du temps\u2026","rel":"","context":"In &quot;Actualit\u00e9s de la recherche clinique&quot;","block_context":{"text":"Actualit\u00e9s de la recherche clinique","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/actualites-de-la-recherche-clinique\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2025\/10\/lIA-dans-la-medecine-1.png?fit=1200%2C972&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2025\/10\/lIA-dans-la-medecine-1.png?fit=1200%2C972&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2025\/10\/lIA-dans-la-medecine-1.png?fit=1200%2C972&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2025\/10\/lIA-dans-la-medecine-1.png?fit=1200%2C972&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2025\/10\/lIA-dans-la-medecine-1.png?fit=1200%2C972&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":14016,"url":"https:\/\/blogdelarechercheclinique.com\/en\/le-risk-based-monitoring-une-nouvelle-approche-du-controle-qualite-2\/","url_meta":{"origin":16340,"position":4},"title":"Le Risk-based monitoring, une nouvelle approche du contr\u00f4le qualit\u00e9","author":"Vanessa Montanari","date":"24 March 2015","format":false,"excerpt":"Depuis quelques ann\u00e9es, nous assistons \u00e0 un v\u00e9ritable changement concernant la fa\u00e7on de r\u00e9aliser le monitoring d\u2019un essai clinique, et ce, \u00e0 l\u2019\u00e9chelle internationale. Dans cet article, nous te proposons de t\u2019expliquer cette notion qui peut para\u00eetre un peu compliqu\u00e9e de prime abord.","rel":"","context":"In &quot;Pratiquer le m\u00e9tier d'Attach\u00e9 de recherche clinique&quot;","block_context":{"text":"Pratiquer le m\u00e9tier d'Attach\u00e9 de recherche clinique","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/pratiquer-le-metier-dattache-de-recherche-clinique\/"},"img":{"alt_text":"Risk-based monitoring","src":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":3817,"url":"https:\/\/blogdelarechercheclinique.com\/en\/jamais-2-3-apres-mr-002-voici-mr-003\/","url_meta":{"origin":16340,"position":5},"title":"En quoi consiste la nouvelle m\u00e9thodologie de recherche MR-003","author":"Vanessa Montanari","date":"20 April 2017","format":false,"excerpt":"Article r\u00e9dig\u00e9 par la Soci\u00e9t\u00e9 Pharmaspecific, sp\u00e9cialiste en recherche clinique Et nous souhaitons la bienvenue \u00e0 \u2026 la nouvelle m\u00e9thodologie de r\u00e9f\u00e9rence MR-003\u00a0! En effet, le 14 ao\u00fbt 2016, le Journal Officiel a publi\u00e9 la d\u00e9lib\u00e9ration n\u00b02016-263 du 21 juillet 2016 portant sur l\u2019homologation d'une m\u00e9thodologie de r\u00e9f\u00e9rence relative aux\u2026","rel":"","context":"In &quot;Les r\u00e8glementaires&quot;","block_context":{"text":"Les r\u00e8glementaires","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/reglementaires\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/posts\/16340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/comments?post=16340"}],"version-history":[{"count":8,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/posts\/16340\/revisions"}],"predecessor-version":[{"id":16366,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/posts\/16340\/revisions\/16366"}],"wp:attachment":[{"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/media?parent=16340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/categories?post=16340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/tags?post=16340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}